Report Overview
The global "Intra-Dialytic Hypotension Market" is anticipated to expand at a rapid CAGR from 2023 to 2030.
IDH is characterised by a drop in systolic blood pressure of at least 20 mmHg or a drop in mean arterial pressure (MAP) of at least 10 mmHg, both of which are associated with symptoms like nausea, abdominal pain, yawning, sighing, vomiting, muscle cramps, restlessness, dizziness or fainting, and anxiety.
For More Insights request free Sample: https://www.datamintelligence.com/download-sample/intra-dialytics-hypotension-market
Market Dynamics
The market for intra-dialytic hypotension is expanding due to the rise in kidney disease patients receiving dialysis treatment internationally. The development of technology in the medical sector is another driver for this industry. Patients can benefit from new technical developments like blood pressure monitors and hemodialysis testing equipment. Ultrafiltration, plasma refill rates (UFR), and plasma volume variations are all calculated with the aid of online hematocrit monitoring tools.
76% of dialysis patients who are part of the global population with renal failure take anti-hypertensive drugs. 15% of hemodialysis patients experience intra-dialytic hypotension.
However, the primary barriers to this market's growth are low purchasing power and hospitals' lack of access to essential services.
View Full Report: https://www.datamintelligence.com/research-report/intra-dialytics-hypotension-market
Intra-Dialytic Hypotension (IDH) Market Companies
Key players Aetna, lighTouch Medical., Cnsystems Medizintechnik, Memscap, Fresenius, Medical Care, SunTech Medical, W. A. Baum, Siemens Corporate Research, Omron healthcare
Related Reports:
Patient Engagement Solutions Market
Smart Implantable Pumps Market
Media Contact
Company Name: DataM Intelligence
Email: [email protected]
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
Sign in to leave a comment.